跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ranolazine Aspire Prolonged-Release Tablets 750 mg Tablets POM - UK EMC Drug Approval Details
Approvals
/
UK EMC
/
Ranolazine Aspire Prolonged-Release Tablets 750 mg Tablets POM
Approved
STANDARD
Ranolazine Aspire Prolonged-Release Tablets 750 mg Tablets POM
Aspire Pharma Ltd
🇬🇧 Electronic Medicines Compendium
Approval Date
N/A
Approval ID
9625a65be1f04005
Company
Aspire Pharma Ltd
Type
Standard
Approval Details
Approval Id
9625a65be1f04005
Drug Approval Emc Name
Ranolazine Aspire Prolonged-Release Tablets 750 mg Tablets POM
Drug Name
Ranolazine Aspire Prolonged-Release Tablets 750 mg Tablets POM
Company Name
Aspire Pharma Ltd
Company Address
4 Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, UK
Company Website
http://www.aspirepharma.co.uk
Company Telephone
+44 (0)1730 231148
Company Medical Info Direct Line
+44 (0)1730 231148
Company Customer Care Direct Line
+44 (0)1730 231148
Atc Code
C01EB18
Legal Category
Prescription only medicine
Active Ingredients
Approved
Quick Info
Agency
UK EMC
Country
🇬🇧
Approval ID
9625a65be1f04005
Type
Standard
Back to UK EMC Approvals